Webinar · Recorded February 2026

ATP Confirmation and You

A practical, no-fluff session on what Authorized Trading Partner confirmation actually requires, and what “good” looks like in the real world. We are joined by Abha Kundi, who developed and directed FDA’s DSCSA program and now covers DSCSA, AI, and more at ArentFox Schiff.

Abha KundiCounsel, ArentFox SchiffFormer FDA DSCSA leadProfile →
Alex ColganLedgerDomain

Watch the recording

Name

What the session covers

Five things to have straight before the next inspection, based on how FDA has actually been enforcing DSCSA.

  • Current DSCSA requirements and where enforcement is actually landing
  • Lessons from FDA’s first DSCSA 483 issued to a dispenser
  • How to document ATP confirmation as real “evidence of review”
  • Why spreadsheets and shared folders no longer survive scrutiny
  • A practical compliance action plan you can start this quarter

More sessions with regulatory and compliance leaders

Oct 2024DSCSA Exemptions and You!With special guest Tish PahlWatch →Sep 2024Tying Up the Loose Ends for DSCSAWith Rx Supply Chain AdvisorsWatch →Jul 2024DSCSA Industry Status and Roadmap to NovemberWith Rx Supply Chain AdvisorsWatch →Jun 2024Unlocking the Value of DSCSA with Credentials and Customer Master DataWith IQVIAWatch →